Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells

Int J Cancer. 2000 Jul 1;87(1):29-36.

Abstract

Five human rhabdomyosarcoma cell lines were used to investigate the surface expression of HER/erbB receptors, particularly of HER-2, HER-3 and HER-4, by flow cytometry. HER-2 was expressed in 3/5 rhabdomyosarcoma cell lines. HER-3 was expressed in all rhabdomyosarcoma cell lines. None of the rhabdomyosarcoma cell lines investigated showed HER-4 surface expression. To study the biological activity of HER/erbB receptors in rhabdomyosarcomas, cells were cultured in the presence of glial growth factor 2 (GGF-2), a specific ligand of HER-3 that is able to stimulate myogenesis in normal myoblasts. In 3 of 3 human rhabdomyosarcoma cell lines positive for both HER-2 and HER-3 receptors, the treatment with GGF-2 induced a significant increase in myogenic differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cell Nucleus / drug effects
  • ErbB Receptors / biosynthesis*
  • Flow Cytometry
  • Humans
  • Ligands
  • Neuregulin-1 / pharmacology*
  • Polymerase Chain Reaction
  • Receptor, ErbB-2 / biosynthesis*
  • Receptor, ErbB-3 / biosynthesis*
  • Receptor, ErbB-4
  • Rhabdomyosarcoma / metabolism*
  • Signal Transduction / drug effects
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Ligands
  • Neuregulin-1
  • ERBB4 protein, human
  • ErbB Receptors
  • Receptor, ErbB-2
  • Receptor, ErbB-3
  • Receptor, ErbB-4